Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 167 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Lymphatic Malformations Phase2, Phase3 Australia
Belgium
France
Germany
Italy
Spain
United States
View All

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Chronic Inducible Urticaria Phase3 Argentina
Australia
Brazil
Canada
China
Colombia
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Malaysia
Netherlands
Poland
Portugal
Romania
Singapore
Slovakia
Spain
Thailand
Turkey
United Kingdom
United States
Vietnam
View All

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Hypercholesterolemia Germany

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Myeloid Leukemia, Philadelphia Positive Phase1, Phase2 China
France
Germany
Greece
Hungary
Italy
Japan
Korea, Republic of
Netherlands
Poland
Russian Federation
Thailand
Turkey
United States
View All

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis Portugal

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Renal Angiomyolipoma Phase4 Taiwan

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

Relapsing Multiple Sclerosis Austria

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Sjogrens Syndrome Phase3 Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Czechia
France
Germany
Greece
Guatemala
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Lithuania
Mexico
Poland
Portugal
Romania
Singapore
Slovakia
South Africa
Spain
Sweden
Taiwan
Turkey
United Kingdom
United States
View All

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

Multiple Sclerosis Switzerland

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

Hidradenitis Suppurativa Russian Federation